Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System.
The Syracuse, New York-based company says the milestone makes its system the first ever reusable intermittent urinary catheter...
Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System.
The Syracuse, New York-based company says the milestone...
Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Microsure, a medical robotics company developing high-precision robot-assisted systems for microsurgery, announced the CE mark approval of its
MUSA-3 system and a leadership transition as...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System.
The Syracuse, New York-based company says the milestone...
Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Microsure, a medical robotics company developing high-precision robot-assisted systems for microsurgery, announced the CE mark approval of its
MUSA-3 system and a leadership transition as...